Drug Information

Drug General Information
Drug ID
D06IGT
Former ID
DNC003756
Drug Name
(3S,4R)-3-Benzyl-7-isopropyl-chroman-4-ol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [551327]
Formula
C19H22O2
Canonical SMILES
CC(C)C1=CC2=C(C=C1)C(C(CO2)CC3=CC=CC=C3)O
InChI
1S/C19H22O2/c1-13(2)15-8-9-17-18(11-15)21-12-16(19(17)20)10-14-6-4-3-5-7-14/h3-9,11,13,16,19-20H,10,12H2,1-2H3/t16-,19+/m0/s1
InChIKey
OJNGOFXPXHHONH-QFBILLFUSA-N
PubChem Compound ID
44314178
Target and Pathway
Target(s) Leukotriene B4 receptor 1 Target Info Inhibitor [551327]
Leukotriene B4 receptor 2 Target Info Inhibitor [551327]
KEGG Pathway Neuroactive ligand-receptor interactionhsa04020:Calcium signaling pathway
Neuroactive ligand-receptor interaction
NetPath Pathway IL4 Signaling Pathway
PANTHER Pathway Inflammation mediated by chemokine and cytokine signaling pathway
Reactome Leukotriene receptors
G alpha (q) signalling eventsR-HSA-391906:Leukotriene receptors
G alpha (q) signalling events
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
Spinal Cord Injury
GPCR ligand binding
GPCR downstream signalingWP2664:Gastrin-CREB signalling pathway via PKC and MAPK
GPCR downstream signaling
GPCRs, Other
References
Ref 5513273-Substituted-4-hydroxy-7-chromanylacetic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor, Bioorg. Med. Chem. Lett. 7(17):2307-2312 (1997).
Ref 5513273-Substituted-4-hydroxy-7-chromanylacetic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor, Bioorg. Med. Chem. Lett. 7(17):2307-2312 (1997).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.